# Filing Detail

Form DRS/A - Draft Registration Statement: [Amend]
SEC Accession No. 0000950123-16-019847
Filing Date
2016-08-12
Accepted
2016-08-12 17:24:15
Documents
12

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | filename1.htm | DRS/A | 2829464
2 | GRAPHIC | g183927g21w10.jpg | GRAPHIC | 33374
3 | GRAPHIC | g183927g28n12.jpg | GRAPHIC | 47260
4 | GRAPHIC | g183927g42b53.jpg | GRAPHIC | 52782
5 | GRAPHIC | g183927g46v89.jpg | GRAPHIC | 105238
6 | GRAPHIC | g183927g50u51.jpg | GRAPHIC | 42520
7 | GRAPHIC | g183927g77f17.jpg | GRAPHIC | 84416
8 | GRAPHIC | g183927g80c75.jpg | GRAPHIC | 52173
9 | GRAPHIC | g183927g84b16.jpg | GRAPHIC | 34581
10 | GRAPHIC | g183927g87t50.jpg | GRAPHIC | 104996
11 | GRAPHIC | g183927g89g09.jpg | GRAPHIC | 49389
12 |  | filename12.htm | COVER | 54673
| Complete submission text file | 0000950123-16-019847.txt |  | 3718418

Mailing Address AESCHENVORSTADT 36 BASEL V8 4051
Business Address AESCHENVORSTADT 36 BASEL V8 4051 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

EIN.: 473173478 | Fiscal Year End: 1231
Type: DRS/A | Act: 33 | File No.: 377-01325 | Film No.: 161829239
SIC: 2836 Biological Products, (No Diagnostic Substances)